Improving Lives for Less
*New data* The 2016 Generic Drug Savings and Access in the U.S. report shows that generic pharmaceuticals saved the U.S. health system $227 billion in 2015. This year’s report features state-by-state savings, therapy area and public program savings and more. Data compiled by the QuintilesIMS Institute. Learn more >
Value and Quality
The Biosimilars Council, a division of the Generic Pharmaceutical Association (GPhA), works to ensure a positive environment for patient access to biosimilar medicines.
Click here for more information.
Epic Challenges. Epic Opportunities.
Are you ready to aspire to new levels of excellence in life and business? Join us at #ACCESS17, the GPhA Annual Meeting where nearly 700 attendees gather to gain insight on how the nation's most critical health and regulatory issues will impact the generic industry and the consumers who benefit from access to affordable medicines. Featuring kenote speaker Captain “Sully” Sullenberger. Register now >